GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21 (Q72347555)
Jump to navigation
Jump to search
scientific article published on 01 July 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21 |
scientific article published on 01 July 1995 |
Statements
GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21 (English)
Helling F
Zhang S
Shang A
Adluri S
Calves M
Koganty R
Longenecker BM
Yao TJ